Document is current
Any future updates will be listed below
-
Authors
DiNardo, Courtney D. https://orcid.org/0000-0001-9003-0390
Konopleva, Marina Y.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA235622, R01CA235622)
- License Information
-
More Information
Article History
First Online: 13 January 2021
Competing interests
: C.D.D. reports research funding from Abbvie, Agios, Calithera, Cleave, BMS/Celgene, Daiichi-Sankyo, ImmuneOnc and Loxo; advisory/consulting for Abbvie, Agios, Celgene/BMS, Daiichi Sankyo, ImmuneOnc, Novartis and Takeda; and stock options from Notable Labs. M.Y.K. reports research funding from AbbVie, Genentech, Eli Lilly, Cellectis, Calithera, Ablynx, Stemline Therapeutics, Sanofi, Rafael and Forty-Seven; advisory/consulting for AbbVie, Genentech, F. Hoffmann–La Roche, Cellectis, Stemline Therapeutics, Kisoji and Forty-Seven; and stock options/royalties from Reata Pharmaceuticals.
